Decheng Reports a Big ALPN Buy

JC Parets
November 15, 2023

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Decheng Capital Management, a hedge fund focused on investing in early-stage life science companies.

Decheng reported a purchase in the biotech company Alpine Immune Sciences $ALPN worth more than $4.6 million.

Here’s The Hot Corner, with data through November 14, 2023:

In another Form 4, Broadwood Partners reported a $1.1 million purchase in medical device company STAAR Surgical $STAA.

Aside from institutional buying, there was also some notable activity from company executives. 

The Custom Truck One Source $CTOS CFO reported a purchase of $340,000, while the CEO of Pebblebrook Hotel $PEB filed for a $208,000 buy.

There was no significant options flow to report.

Stay tuned. We'll be back on Thursday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under: